PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for...

MindMed Becomes Second Psychedelic Drug Development Company to List on the...

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement...

Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Mydecine to Report Full Year 2020 Financial Results on May 3,...

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction...

Red Light Holland and Headland West Indies Lead #SVGStrong, a Relief...

Psychedelic Bulletin: MindMed to List on Nasdaq; Atai IPO Unveiled; Champignon...

PTSF56 – Data vs. Spin, with Tim Cools of Psychedelic Experience

MindMed To Commence Trading on Nasdaq

Load more